AN2 Therapeutics
ANTX
ANTX
38 hedge funds and large institutions have $94.8M invested in AN2 Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.84% less ownership
Funds ownership: 50.32% → 49.49% (-0.84%)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$518K | |
| 2 | +$377K | |
| 3 | +$216K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$124K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$109K |
Top Sellers
| 1 | -$2M | |
| 2 | -$1.02M | |
| 3 | -$201K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$46.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$10.4K |